Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MSPS Focuses on Design of New Lens Production Facility

Published: Saturday, March 15, 2014
Last Updated: Friday, March 14, 2014
Bookmark and Share
Company has won a significant contract to support the design of new facility.

Morgan Sindall Professional Services (MSPS) has won a significant contract for a world-leading life sciences business to support the design and build of a new, best-in-class production facility for completion in 2015.

Rayner Intraocular Lenses, whose products have been used to surgically restore the sight of millions of people worldwide, are building a new facility to meet global demand. MSPS is providing the civil and structural, process, mechanical and electrical, architectural, BREEAM and CDM services for the new development.

The consultancy, which has designed over 2 million sq ft of clean room space over the past 20 years, was tasked with developing options for the refurbishment of an alternative building as well as the selected option of a new, highly-efficient facility.

The new brownfield development is close enough to Rayner’s existing facility to retain its highly skilled, specialized workforce and the consultancy will support a phased occupation to take place, ensuring no interruption to production.

Mark Dickson, director for manufacturing and life sciences says that MSPS was chosen for its leading experience in complex manufacturing: “We have delivered a design that makes intelligent use of internal space to ensure increased output and a reduction in operating costs. Our design goes beyond building regulations to reduce energy consumption, which is detailed on a per lens basis,” he explains.

“The facility is designed to achieve BREEAM ‘very good’ status for the low carbon technology used in the facility.”

Good Manufacturing Practice (GMP) is key to the design of the new facility, and integral to all aspects of the building including its use of space, operation, the materials used and their cleaning and maintenance.

MSPS’ front-end engineering and process skills were employed to develop User Requirement Specifications (URS) and the multidisciplinary design solution was developed in a BIM environment, co-ordinated through Revit in order that MSPS could clearly and visually communicate the design’s attributes and benefits.

Part of the process engineering consultation was in the design of bespoke equipment; MSPS’ role was to identify the equipment specification and effectively translate these detailed and exacting requirements to the supplying vendors. This equipment will deliver the greatest efficiency and benefits to the business’ production.

Martin Jamieson, Rayner CEO commented that implantable medical devices are subject to rigorous technical and quality standards, imposed by the regulatory authorities around the world: “In partnership with MSPS Rayner will deliver a state-of-the-art manufacturing facility producing intraocular lenses for sale to markets worldwide. The decision to base the facility in the UK is a tribute to the quality and productivity leap that will be achieved in this country. Rayner will also move its global headquarters to the new facility.”

The detail design phase will be completed in early 2014, allowing the start of construction, which is due for completion in October 2015.

Rayner Intraocular Lenses is the only manufacturer of intraocular lenses in the UK. The company is a member of the Rayner group of companies which has had interests in optics since it was established in 1910.

Having predicted reaching maximum production capacity in its existing facility, Rayner put out to tender a brief that would future proof its production capabilities.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!